These results suggest that the LHb CaMKII–AMPAR signaling pathway may be a potential target and provide a new therapeutic approach not only to relieve symptoms of depression, but also to alleviate the desire for alcohol consumption [7]. The gene discussed is LHB; the disease is depressive symptom measurement.